These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21945902)

  • 1. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
    Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; Guillozet-Bongaarts AL; Ward SM; He B; Kanaan NM; Mufson EJ; Binder LI; Counts SE
    Neurobiol Aging; 2016 Jun; 42():80-90. PubMed ID: 27143424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
    Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
    Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.
    Tiernan CT; Mufson EJ; Kanaan NM; Counts SE
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):246-259. PubMed ID: 29378005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
    Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
    J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study.
    Mufson EJ; Perez SE; Nadeem M; Mahady L; Kanaan NM; Abrahamson EE; Ikonomovic MD; Crawford F; Alvarez V; Stein T; McKee AC
    Brain Inj; 2016; 30(12):1399-1413. PubMed ID: 27834536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Che S; Counts SE; Mufson EJ
    J Neurochem; 2006 Mar; 96(5):1401-8. PubMed ID: 16478530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease.
    Mufson EJ; Ward S; Binder L
    Neurodegener Dis; 2014; 13(2-3):151-3. PubMed ID: 24029627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
    Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
    J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.
    Alexandris AS; Walker L; Liu AKL; McAleese KE; Johnson M; Pearce RKB; Gentleman SM; Attems J
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):264-278. PubMed ID: 31454423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.
    Mufson EJ; Ginsberg SD; Ikonomovic MD; DeKosky ST
    J Chem Neuroanat; 2003 Dec; 26(4):233-42. PubMed ID: 14729126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed.
    Voss K; Koren J; Dickey CA
    Am J Pathol; 2011 Nov; 179(5):2148-51. PubMed ID: 21964186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.
    Ahmadian SS; Rezvanian A; Peterson M; Weintraub S; Bigio EH; Mesulam MM; Geula C
    Neurobiol Aging; 2015 Dec; 36(12):3163-3170. PubMed ID: 26417681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the basal forebrain in Alzheimer's disease.
    Jacobs RW; Duong T; Scheibel AB
    Mol Chem Neuropathol; 1992 Aug; 17(1):1-20. PubMed ID: 1388447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.
    Perez SE; Miguel JC; He B; Malek-Ahmadi M; Abrahamson EE; Ikonomovic MD; Lott I; Doran E; Alldred MJ; Ginsberg SD; Mufson EJ
    Acta Neuropathol; 2019 Mar; 137(3):413-436. PubMed ID: 30734106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.